ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma

Gliomas are malignant central nervous system tumors characterized by poor prognosis and therapy failure. Adenosine triphosphate-binding cassette (ABC) transporters mediate multidrug resistance via chemotherapeutic efflux, yet their roles as biomarkers across glioma subtypes remain unclear. We analyzed adult diffuse glioma mRNA expression (n = 693; n = 325) and DNA methylation (n = 159) datasets from the Chinese Glioma Genome Atlas in silico, stratifying samples according to the 2021 World Health Organization molecular criteria. ABC transporter profiles, patient-matched methylation–expression correlations (n = 26 overlapping patients; 78 paired gene–sample observations), and prognostic values were evaluated using non-parametric tests with false discovery rate (FDR) correction, Kaplan–Meier curves, and multivariable Cox proportional-hazards regression analyses. Transporter expression and methylation varied significantly by histology and grade. ABCC1 expression increased with malignancy, predicting worse overall survival in univariable analysis (p < 0.0001). Meanwhile, strongly correlated ABCB1 and ABCG2 expressions (Spearman’s ρ = 0.80 in grade 4 tumors) were higher in lower-grade gliomas. Progressive hypomethylation occurred with increasing grade, with significant differential methylation in ABCB1 (FDR p < 0.0001) and ABCG2 (FDR p < 0.0001). In patient-matched integrative analyses, only ABCC1 exhibited a significant inverse association between methylation and expression (Spearman’s ρ = −0.58, p = 0.0019). Baseline clinical multivariable Cox regression (n = 139) suggested that higher ABCB1 and ABCG2 methylation (HR = 0.11, p = 0.03; HR = 0.12, p = 0.04 per 1.0-unit β increase, corresponding to HR = 0.80 and 0.81 per 0.1-unit β increase) may act as protective factors independent of age and grade (though attenuated upon IDH adjustment), whereas higher grade and ABCG2 expression (n = 542; HR = 1.03, p = 0.001) emerged as independent risk factors. Specific ABC transporter profiles could serve as candidate prognostic biomarkers in glioma, warranting external and translational validation.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-13
DOI
https://doi.org/10.3390/ijms272210180
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma

Vivaldo Moura‐Neto, Carlos Pilotto Heming, Veronica Aran, Yasminn Meireles
International Journal of Molecular Sciences
Glioma Diagnosis and Treatment
article

ATP-Binding Cassette Transporter Expression and Methylation Profiles as Potential Biomarkers in Glioma

Vivaldo Moura‐Neto, Carlos Pilotto Heming, Veronica Aran, Yasminn Meireles
article en

Abstract

Gliomas are malignant central nervous system tumors characterized by poor prognosis and therapy failure. Adenosine triphosphate-binding cassette (ABC) transporters mediate multidrug resistance via chemotherapeutic efflux, yet their roles as biomarkers across glioma subtypes remain unclear. We analyzed adult diffuse glioma mRNA expression (n = 693; n = 325) and DNA methylation (n = 159) datasets from the Chinese Glioma Genome Atlas in silico, stratifying samples according to the 2021 World Health Organization molecular criteria. ABC transporter profiles, patient-matched methylation–expression correlations (n = 26 overlapping patients; 78 paired gene–sample observations), and prognostic values were evaluated using non-parametric tests with false discovery rate (FDR) correction, Kaplan–Meier curves, and multivariable Cox proportional-hazards regression analyses. Transporter expression and methylation varied significantly by histology and grade. ABCC1 expression increased with malignancy, predicting worse overall survival in univariable analysis (p < 0.0001). Meanwhile, strongly correlated ABCB1 and ABCG2 expressions (Spearman’s ρ = 0.80 in grade 4 tumors) were higher in lower-grade gliomas. Progressive hypomethylation occurred with increasing grade, with significant differential methylation in ABCB1 (FDR p < 0.0001) and ABCG2 (FDR p < 0.0001). In patient-matched integrative analyses, only ABCC1 exhibited a significant inverse association between methylation and expression (Spearman’s ρ = −0.58, p = 0.0019). Baseline clinical multivariable Cox regression (n = 139) suggested that higher ABCB1 and ABCG2 methylation (HR = 0.11, p = 0.03; HR = 0.12, p = 0.04 per 1.0-unit β increase, corresponding to HR = 0.80 and 0.81 per 0.1-unit β increase) may act as protective factors independent of age and grade (though attenuated upon IDH adjustment), whereas higher grade and ABCG2 expression (n = 542; HR = 1.03, p = 0.001) emerged as independent risk factors. Specific ABC transporter profiles could serve as candidate prognostic biomarkers in glioma, warranting external and translational validation.

International Journal of Molecular SciencesVol. 27(22)
Universidade Federal do Rio de Janeiro (BR), Instituto Estadual do Cérebro Paulo Niemeyer (BR)
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon